ACERAGEN INC (ACGN)

US00445F1093 - Common Stock

1.62  0 (0%)

News Image
4 months ago - Aceragen, Inc.

Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study

DURHAM, N.C. and EXTON, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (Nasdaq: ACGN) a clinical-stage biopharmaceutical company...